CN106176600A — 一种前列地尔冻干微乳剂、原料组合物及其制备方法
Assigned to Shanghai Advanced Pharmaceutical Engineering Research Center Ltd · Expires 2016-12-07 · 9y expired
What this patent protects
本发明公开了一种前列地尔冻干微乳剂、原料组合物及其制备方法,其原料组合物包括0.1~10mg/100mL的前列地尔、0.5~20g/100mL的油、0.5~30g/100mL的乳化剂、0.5~2g/100mL的助乳化剂、5~40mg/100mL的稳定剂、5~20g/100mL的冻干保护剂、0.5~500mg/100mL的pH调节剂和余量的水。其制备方法包括:在惰性氛围下制得油相和水相,将水相以0.5~5mL/min的滴加速度滴入油相中,于30~50℃下剪切乳化得到微乳;之后调节微乳pH至3.0~6.0,经无菌过滤,冷冻干燥即得。本发明的前列地尔冻干微乳剂…
USPTO Abstract
本发明公开了一种前列地尔冻干微乳剂、原料组合物及其制备方法,其原料组合物包括0.1~10mg/100mL的前列地尔、0.5~20g/100mL的油、0.5~30g/100mL的乳化剂、0.5~2g/100mL的助乳化剂、5~40mg/100mL的稳定剂、5~20g/100mL的冻干保护剂、0.5~500mg/100mL的pH调节剂和余量的水。其制备方法包括:在惰性氛围下制得油相和水相,将水相以0.5~5mL/min的滴加速度滴入油相中,于30~50℃下剪切乳化得到微乳;之后调节微乳pH至3.0~6.0,经无菌过滤,冷冻干燥即得。本发明的前列地尔冻干微乳剂粒径小、包封率高、稳定安全、高效靶向。
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.